A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt

Baher Elezbawy1 Syreon Middle East,Alexandria,Egypt.Correspondence[email protected]

Ahmad Nader Fasseeh1 Syreon Middle East,Alexandria,Egypt.;2 Eötvös Loránd University,Budapest,Hungary.

Amal Sedrak3 The Egyptian Authority for Unified Procurement, Medical Supply, and The Management of Medical Technology (UPA),Cairo,Egypt.

Randa Eldessouki4 Fayoum University,Fayoum,Egypt.

Mary Gamal3 The Egyptian Authority for Unified Procurement, Medical Supply, and The Management of Medical Technology (UPA),Cairo,Egypt.

Mariam Eldebeiky3 The Egyptian Authority for Unified Procurement, Medical Supply, and The Management of Medical Technology (UPA),Cairo,Egypt.

Hanaa Amer5 Ain Shams University,Cairo,Egypt.

Shimaa Akeel3 The Egyptian Authority for Unified Procurement, Medical Supply, and The Management of Medical Technology (UPA),Cairo,Egypt.

Ahmad Morsy6 Presidential Program for Women’s Health, Ministry of Health and Population (MoHP,Cairo,Egypt.

Amira Amin7 Egyptian Pharmaceutical Vigilance Center, Egyptian Drug Authority (EDA),Cairo,Egypt.

Amr Shafik5 Ain Shams University,Cairo,Egypt.

Sherif Abaza8 Syreon Middle East,Cairo,Egypt.

Zoltán Kaló9 Semmelweis University,Budapest,Hungary.;10 Syreon Research Institute,Budapest,Hungary.

Your download is now in progress and you may close this window